Serial Number 88799212
Registration 6136258
700

Registration Progress

Application Filed
Feb 15, 2020
Under Examination
Approved for Publication
Jun 9, 2020
Published for Opposition
Jun 9, 2020
Registered
Aug 25, 2020

Trademark Image

Basic Information

Serial Number
88799212
Registration Number
6136258
Filing Date
February 15, 2020
Registration Date
August 25, 2020
Published for Opposition
June 9, 2020
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Aug 25, 2020
Registration
Registered
Classes
005

Rights Holder

Alnylam Pharmaceuticals, Inc.

03
Address
300 Third Street
Cambridge, MA 02142

Ownership History

Alnylam Pharmaceuticals, Inc.

Original Applicant
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Owner at Publication
03
Cambridge, MA

Alnylam Pharmaceuticals, Inc.

Original Registrant
03
Cambridge, MA

Legal Representation

Attorney
Timothy H. Hiebert

USPTO Deadlines

Next Deadline
388 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-08-25)
Due Date
August 25, 2026
Grace Period Ends
February 25, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

12 events
Date Code Type Description Documents
Aug 25, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Jun 14, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jun 14, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jun 14, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jun 9, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jun 9, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
May 20, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
May 7, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
May 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 22, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Feb 21, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 19, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of transthyretin-mediated amyloidosis; Pharmaceutical preparations for the treatment of familial amyloidotic polyneuropathy
First Use Anywhere: Aug 13, 2018
First Use in Commerce: Aug 13, 2018

Additional Information

Design Mark
The mark consists of a stylized representation of the DNA molecule, between the upper strands of which is a roughly triangular shape.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005